
Abbott Laboratories
NEWS
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 15, 2020.
Following a study that raises concerns about the accuracy of Abbott’s rapid COVID-19 test for detecting the virus, the U.S. Food and Drug Administration (FDA) announced it will investigate the claims found in a New York University-related study as the company updates its guidance on the ID NOW test.
Researchers at a New York hospital compared Abbott’s 15-minute Abbott ID NOW test to another COVID-19 diagnostics device and found that the Abbott system missed 48% of positive cases the other device detected.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 14, 2020.
Approval of Abbott’s latest antibody test comes days after the FDA tightened its rules regarding the regulatory requirement for them.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 6, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 30, 2020.
JOBS
IN THE PRESS